Description
Refalgin
CE medical device with mechanical action in the form of swallowable film-coated tablets with rapid gastric dissolution.Tablets based on alginate derived from seaweed, indicated in the treatment of gastric reflux in order to reduce the symptoms related to it. It can be used during continuous treatment with nonsteroidal anti-inflammatory drugs as primary prophylaxis of gastropathy from NSAIDs.
Ingredients
Alginic acid 365 mg; sodium alginate 300 mg; calcium carbonate; maltodextrin; sodium chloride; microcrystalline cellulose; silicon dioxide; simethicone; hydrogenated vegetable fat; magnesium stearate; water; film coating: hydroxypropylcellulose.
How to use
Swallow 1 - 2 tablets after meals with a little water.
Wash your hands before and after using the medical device.
The duration of use depends on the evolution of the symptoms, if necessary Refalgin tablets can be taken for prolonged periods.
Warnings
Do not use in case of individual hypersensitivity to one of the components of the product.
Safety of use during pregnancy and breastfeeding has not been demonstrated. In such circumstances it is advisable to consult your doctor.
There are no known interactions with other products, therefore it is advisable to consult your doctor before using Refalgin tablets in association with other medical devices or drugs.
Keep out of the reach and sight of children.
Conservation
Store the product tightly closed in a cool, dry place.
Format
Pack of 20 tablets of 1.3 g.
CE mark registration number
0373
